ArticleBMC medicine2026
Epigenetic aging markers in the association between frailty and mortality among U.S. adults.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Posterior Communicating Artery Aneurysm Microsurgery: PComA-CORE, an Anatomy-Informed Explainable AI Framework for Complexity, Neurovascular Risk, Oculomotor Recovery and Functional Outcome.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFrailty reflects diminished physiological reserve and increased vulnerability to adverse health outcomes. It has been linked to biological aging, including epigenetic age acceleration (EAA), a DNA methylation-based marker of aging, but the extent to which EAA accounts for the frailty-mortality association remains unclear.
methodsWe analyzed three U.S. cohorts-NHANES (1999-2002), HRS (2016), and HANDLS (2004-2009)-with mortality follow-up through 2019-2022. Frailty was defined using harmonized adaptations of the Fried phenotype and FRAIL scale. EAA was derived from five epigenetic clocks (Horvath, Hannum, PhenoAge, GrimAge, DunedinPoAm). Additive Bayesian networks, Cox proportional hazards models, and counterfactual four-way decomposition were used to assess potential mediation and moderation of the frailty-mortality association by EAA, adjusting for age, sex, race/ethnicity, and socioeconomic status.
resultsFrailty was strongly associated with higher all-cause mortality in NHANES and HRS. GrimAge and DunedinPoAm showed the strongest mediation. In NHANES, GrimAge accounted for 33% (p < 0.001) and DunedinPoAm mediated 17% (p = 0.006) of the association. In HRS, DunedinPoAm mediated 9% (p = 0.040) and GrimAge 16% (p = 0.020). Other clocks showed limited mediation. HANDLS findings were consistent. Higher socioeconomic status was associated with slower aging and lower frailty risk. Female sex was inversely associated with multiple epigenetic clocks but positively associated with frailty.
conclusionsEpigenetic aging, particularly GrimAge and DunedinPoAm, may explain part of the frailty-mortality association, supporting a role for biological aging pathways linking frailty to mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.